Welcome the webpage of the Cutting Edge Science Symposium on Genome Engineering for Cancer Treatment (The Frank and Bobbie Fenner Conference), held in Canberra Nov 2017.
The symposium will explore the potentially revolutionary field of personalized cancer treatment using CRISPR-Cas9-based genome editing. This technology allows for the accurate editing of DNA and has become a powerful tool for researchers. Recently, the US National Institutes of Health has approved the use of CRISPR–Cas9 for cancer treatment, ringing in a new era of CRISPR applications in human health.
The new application in human health requires particularly the specificity and personalization of the genome editing to be improved. New Big Data enabled analytics methods have been developed to address these challenges and deliver the efficiency and safety required for clinical application in humans.
The symposium will hence bring together International researchers and medical experts, to discuss specific application areas and how to improve CRISPR efficiency for human application.
The symposium will be held in Canberra, Australia’s capital city. Canberra is known for its stylish restaurants, hip bars, boutique shopping, fun kid’s activities, great outdoor recreation and a busy calendar of events and festivals.
Stay in contact:
Download our advertising poster:
|high quality for print||optimized for email|